Stay updated with breaking news from Deep Phenotyping. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature Medicine.
A machine-learning model can identify patients at risk of a rare cardiomyopathy, according to a study published in Nature Communications.
Northwestern University Feinberg School of Medicine has been awarded two grants totaling $18.1 million to study the most common type of heart failure